TREATMENT NOT WORKING
Your diagnosis may be right. Your treatment plan may be incomplete.
WGS analyzes 4.6 to 5M variants including those missed by specialist panels. Your genes determine which treatments are most likely to work, and which are not.
GENETIC SUBTYPES
The subtype determines the treatment. Standard panels were not designed to find it.
LUNG CANCER
27 subtypes
EGFR, ALK, and KRAS mutations each require different targeted therapies. Without subtype identification, treatment selection is incomplete.
EPILEPSY
75+ subtypes
SCN1A mutations respond dangerously to sodium channel blockers. The wrong medication, prescribed based on the right diagnosis, can worsen seizures.
CARDIOMYOPATHY
Multiple variants
Different genetic variants of cardiomyopathy require fundamentally different treatment protocols. The variant determines the approach.
PHARMACOGENOMICS
132 drugs analyzed
14 drug categories, including 46 psychiatric medications. Your genome determines how you metabolize each one, and whether your current dose is right.
ONCOLOGY
Already diagnosed with cancer?
Tumor subtype profiling through our dedicated oncology team can identify the specific genetic drivers of your cancer, enabling targeted treatment selection that standard histology cannot provide.
Speak with our oncology team arrow_forwardCOVERAGE COMPARISON
What a standard panel misses.
STANDARD GENETIC PANEL
30 to 150
genes examined
Specialist panels are designed to confirm suspected conditions. They test a narrow, pre-selected set of genes. If the answer falls outside that set, the panel will not find it.
DANTE WHOLE GENOME SEQUENCING
20,000+
genes sequenced
4.6 to 5M
variants identified
Every gene, every intergenic region. WGS reads the complete genome, including structural variants, deep intronic variants, and pharmacogenomic markers that panels are not built to detect.
CLINICAL REPORTS
Reports your specialist can act on.
ACMG-classified variants
Every reported variant is classified according to ACMG/AMP guidelines: pathogenic, likely pathogenic, variant of uncertain significance, likely benign, or benign.
NHS-accepted formatting
Reports are structured in the format accepted by NHS clinicians and specialists worldwide. Your physician receives results they can integrate directly into clinical decision-making.
Genome Manager AI
Ask questions about your results in plain language. The Genome Manager AI interprets your genomic data and helps you understand what your variants mean for treatment.
SAMPLE FINDING
What a pharmacogenomic report looks like.
GENE
CYP2D6
STATUS
Poor Metabolizer
FINDING
12
affected medications
3
drug categories
CLASSIFICATION
Clinically Actionable
Find your genetic subtype.
Your genome holds the information your treatment plan may be missing. One test sequences everything. Results in 6 to 8 weeks.
From $449
Ships within 48 hours. Results in 6 to 8 weeks.
BNPL / HSA / FSA ELIGIBLE